<p xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Par4">Considering that COVID-19 vaccination reduces the risk of complications such as AIS during infection, it may also be associated with lower risk of severe sequelae from AIS in the setting of COVID-19 breakthrough infection. Therefore, we compared the risk of mortality and serious complications between those with and without COVID-19 vaccination who experienced AIS in the setting of recent COVID-19 breakthrough infection (COVID-19-associated AIS cases) using a large, deidentified, international patient database.</p>